113 related articles for article (PubMed ID: 27758690)
1. Synthesis, Characterization and Antimicrobial Evaluation of Lipid Based Norfloxacin Prodrug.
Sharma PC; Piplani M; Rajak H
Curr Drug Deliv; 2018 Feb; 15(2):219-226. PubMed ID: 27758690
[TBL] [Abstract][Full Text] [Related]
2. Diglyceride prodrug strategy for enhancing the bioavailability of norfloxacin.
Dhaneshwar S; Tewari K; Joshi S; Godbole D; Ghosh P
Chem Phys Lipids; 2011 May; 164(4):307-13. PubMed ID: 21477584
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of N-Mannich based prodrugs of ciprofloxacin and norfloxacin:
Piplani M; Rajak H; Sharma PC
J Adv Res; 2017 Jul; 8(4):463-470. PubMed ID: 28721301
[TBL] [Abstract][Full Text] [Related]
4. Insight into Prodrugs of Quinolones and Fluoroquinolones.
Sharma PC; Piplani M; Mittal M; Pahwa R
Infect Disord Drug Targets; 2016; 16(3):140-161. PubMed ID: 27558786
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, antibacterial activity and physicochemical parameters of novel N-4-piperazinyl derivatives of norfloxacin.
Abuo-Rahma Gel-D; Sarhan HA; Gad GF
Bioorg Med Chem; 2009 Jun; 17(11):3879-86. PubMed ID: 19419875
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antimicrobial evaluation of novel benzimidazole type of Fluconazole analogues and their synergistic effects with Chloromycin, Norfloxacin and Fluconazole.
Zhang HZ; Damu GL; Cai GX; Zhou CH
Eur J Med Chem; 2013 Jun; 64():329-44. PubMed ID: 23644216
[TBL] [Abstract][Full Text] [Related]
7. A Drug-Drug Salt Hydrate of Norfloxacin and Sulfathiazole: Enhancement of in Vitro Biological Properties via Improved Physicochemical Properties.
Gopi SP; Ganguly S; Desiraju GR
Mol Pharm; 2016 Oct; 13(10):3590-3594. PubMed ID: 27580175
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of gastroretentive norfloxacin floating tablets.
Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K
Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145
[TBL] [Abstract][Full Text] [Related]
10. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
Jana S; Mandlekar S; Marathe P
Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
[TBL] [Abstract][Full Text] [Related]
11. Lipidic prodrug approach for improved oral drug delivery and therapy.
Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
[TBL] [Abstract][Full Text] [Related]
12. Poly (ethylene glycol) prodrug for anthracyclines via N-Mannich base linker: design, synthesis and biological evaluation.
Zhao YJ; Wei W; Su ZG; Ma GH
Int J Pharm; 2009 Sep; 379(1):90-9. PubMed ID: 19540322
[TBL] [Abstract][Full Text] [Related]
13. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
Krise JP; Charman WN; Charman SA; Stella VJ
J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
[TBL] [Abstract][Full Text] [Related]
14. (Acyloxy)alkyl carbamate prodrugs of norfloxacin.
Alexander J; Fromtling RA; Bland JA; Pelak BA; Gilfillan EC
J Med Chem; 1991 Jan; 34(1):78-81. PubMed ID: 1992156
[TBL] [Abstract][Full Text] [Related]
15. Microwave assisted synthesis of some hybrid molecules derived from norfloxacin and investigation of their biological activities.
Mentese MY; Bayrak H; Uygun Y; Mermer A; Ulker S; Karaoglu SA; Demirbas N
Eur J Med Chem; 2013 Sep; 67():230-42. PubMed ID: 23871903
[TBL] [Abstract][Full Text] [Related]
16. A prodrug approach toward the development of water soluble fluoroquinolones and structure--activity relationships of quinoline-3-carboxylic acids.
Baker WR; Cai S; Dimitroff M; Fang L; Huh KK; Ryckman DR; Shang X; Shawar RM; Therrien JH
J Med Chem; 2004 Sep; 47(19):4693-709. PubMed ID: 15341485
[TBL] [Abstract][Full Text] [Related]
17. A lipophilic prodrug of Danshensu: preparation, characterization, and in vitro and in vivo evaluation.
Guo XJ; Fan XJ; Qiao B; Ge ZQ
Chin J Nat Med; 2017 May; 15(5):355-362. PubMed ID: 28558871
[TBL] [Abstract][Full Text] [Related]
18. Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability.
Kłosińska-Szmurło E; Pluciński FA; Grudzień M; Betlejewska-Kielak K; Biernacka J; Mazurek AP
J Biol Phys; 2014 Sep; 40(4):335-45. PubMed ID: 25033818
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological properties of conjugates between fluoroquinolones and a N3''-functionalized pyochelin.
Noël S; Gasser V; Pesset B; Hoegy F; Rognan D; Schalk IJ; Mislin GL
Org Biomol Chem; 2011 Dec; 9(24):8288-300. PubMed ID: 22052022
[TBL] [Abstract][Full Text] [Related]
20. A label-free microfluidic assay to quantitatively study antibiotic diffusion through lipid membranes.
Cama J; Chimerel C; Pagliara S; Javer A; Keyser UF
Lab Chip; 2014 Jul; 14(13):2303-8. PubMed ID: 24825393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
